Canopy Growth Corporation is a leading cannabis company focused on medical and adult-use cannabis, hemp, and related products, operating in Canada, Europe, Australia, and the U.S.

# Company Overview: Canopy Growth Corporation

## Business Description
- **Industry Focus:** Medical and adult-use (recreational) cannabis, hemp, and cannabis-related products.
- **Core Operations:** Located in Canada, Germany, and Australia; significant non-controlling interest in U.S. based Canopy USA.
- **Primary Markets:** 
  - **Canada:** Medical and adult-use cannabis
  - **Europe:** Medical cannabis via Spectrum Therapeutics
  - **Australia:** Medical cannabis via Spectrum Therapeutics
- **Product Formats:** 
  - Dried cannabis flower
  - Pre-rolled joints (PRJ)
  - Oils and concentrates
  - Edibles (including gummies)
  - Softgel capsules
  - Vaporizer devices (including medical/vape-certified products)
  - Accessories (vaporizers from Storz & Bickel)
  
## Brand Portfolio
- **Adult-Use Brands:** Tweed (flagship), 7ACRES, Maitri, HiWay, Twd., Wana, Claybourne, Deep Space
- **Medical Brands:** Spectrum Therapeutics (Canada), Canopy Medical (Europe)
- **Device Brands:** Storz & Bickel (Germany)
- **Other:** Formerly owned “This Works” (sold in December 2023)

## Market and Revenue
- **Canadian Medical Cannabis:** 
  - Serves registered patients via online sales
  - Support programs for veterans, low-income, private insurance
  - As of March 31, 2025, 7,794 patients in Canada enrolled in Spectrum’s compassionate pricing
- **Canadian Adult-Use Market:** 
  - Operates cultivation facilities in Ontario and British Columbia
  - Distributes through provincial and private retail outlets
  - Focused on premium and innovative products like flower, vapes, gummies, oils
- **International Markets:** 
  - Supplies medical cannabis in Germany, Poland, and Australia
  - Operates under EU-GMP standards
- **Vaporizer Operations:** 
  - Produces and sells medical vaporizers (volcano, Mighty, Crafty) and dry herb vaporizers (Venty)
  - Sold in over 100 markets worldwide
  
## Financial Highlights
- **Employees:** 
  - Total employees as of March 31, 2025: 960 
  - In Canada: 728 employees
  - Outside Canada: 232 employees (mainly supporting international and vaporizer businesses)
- **Number of Shares Outstanding:** 
  - As of May 28, 2025: 185,192,210 common shares
  - 26,261,474 non-voting exchangeable shares (convertible at holder’s discretion)
- **Market Capitalization:** 
  - Approximate value of non-affiliate held shares as of September 30, 2024: **$452 million CAD**
- **Revenue (Fiscal Year Ended March 31, 2025):** 
  - Not explicitly provided in the excerpt (please refer to financial statements for exact figures)
- **Net Income / Loss:** 
  - Not explicitly provided in the excerpt; the company has incurred losses in recent years and continues to invest heavily for growth

## Strategic Focus
- Expand and support medical cannabis globally with high-quality products
- Lead in vaporization and innovative cannabis formats
- Strengthen and grow brands in adult-use cannabis, focusing on quality, safety, and consumer loyalty
- Leverage a disciplined asset-right operating model for efficiency
- Maximize U.S. market exposure through strategic investments in Canopy USA (with caution regarding federal legal restrictions)

**Note:** The 10-K emphasizes risks, regulatory environment, and ongoing legal and financial complexities, but does not provide specific recent revenue or net income figures in the provided excerpt.

Canopy Growth Corporation is a leading Canadian cannabis company that produces, distributes, and sells a wide range of cannabis products and is expanding its market presence globally.

# Company Overview: Canopy Growth Corporation

## Business Description
Canopy Growth Corporation is a leading cannabis company based in Canada that produces, distributes, and sells a diverse range of cannabis and cannabis-related products, including medical and adult-use cannabis. The company operates under multiple well-known brands, such as Tweed, 7ACRES, Wana, and Spectrum Therapeutics. 

### Core Operations
- **Regions of Operation**:  
  - Canada (primary market)
  - Significant operations in Germany and Australia
  - Holds a non-controlling interest in Canopy USA, which is involved in the U.S. cannabis market.

- **Product Offerings**:  
  - **Cannabis Products**: Dried flower, pre-rolled joints, oils, softgel capsules, infused beverages, edibles (gummies), topicals, and vaporizer devices.
  - **Hemp-Derived CBD Products**: Includes the Martha Stewart CBD line, which consists of gummies, oils, softgels, and topicals.
  - **Devices**: Premier herbal vaporizer devices through Storz & Bickel.
  
### Market Position
- **Total Revenue**: As of the fiscal year ended March 31, 2024, the company reported approximately $122.7 million in sales to cannabis control authorities in Canada for its adult-use products.
  
- **Customer Base**: The company serves both medical and adult-use markets. It distributes its products across all Canadian provinces and territories through provincial control boards and retail channels.

### Workforce
- **Number of Employees**: As of March 31, 2024, Canopy Growth had a total of 1,029 employees, with 790 employees in Canada and 239 employees outside of Canada, primarily supporting international medical cannabis operations.

### Financial Performance
- **Recent Challenges**: Canopy Growth has incurred significant losses over the past fiscal years, with negative operating cash flow reported since 2019, including for the fiscal year ending March 31, 2024.
  
- **Profitability Outlook**: The company emphasizes the potential to achieve profitability in the future by leveraging its expansion into the U.S. cannabis market through Canopy USA, as well as continuous investments in product innovation and brand development.

## Core Values and Strategic Focus
- **Vision**: To unleash the power of cannabis to improve lives while fostering a responsible, innovative, and purpose-driven atmosphere for its employees.
  
- **Social Justice Advocacy**: Committed to supporting initiatives that address the harms of cannabis prohibition and promote social equity in the cannabis industry.

- **Operational Strategy**: Focused on building consumer brands, optimizing production through an asset-light model, enhancing direct-to-consumer relationships, and expanding their market presence internationally.

### Key Initiatives
- Partnerships with various organizations to promote responsible cannabis use and community engagement.
- Continuous development and launch of new products catering to evolving consumer preferences in both medical and recreational cannabis markets.

## Conclusion
Canopy Growth Corporation stands as a frontrunner in the cannabis sector, emphasizing consumer safety, product quality, operational efficiency, and social responsibility. While facing challenges in achieving profitability and navigating a competitive market landscape, the company’s strategic efforts and market position provide a foundation for potential future growth and success.

Canopy Growth Corp

10-K / May 30, 2025

10-K / May 30, 2024

10-K / May 30, 2025

Company Overview: Canopy Growth Corporation

Business Description

Brand Portfolio

Market and Revenue

Financial Highlights

Strategic Focus